1. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial. Issue 10279 (20th March 2021) Authors: Butler, Christopher C; Dorward, Jienchi; Yu, Ly-Mee; Gbinigie, Oghenekome; Hayward, Gail; Saville, Benjamin R; Van Hecke, Oliver; Berry, Nick; Detry, Michelle; Saunders, Christina; Fitzgerald, Mark; Harris, Victoria; Patel, Mahendra G; de Lusignan, Simon; Ogburn, Emma; Evans, Philip H; Thomas, Ni... Journal: Lancet Issue: Volume 397:Issue 10279(2021) Page Start: 1063 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗